Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Protagen and ZAP Partner with Kangdi Antibody Biotech and Bejing Proteome Research Centre to Develop Antibodies

Published: Wednesday, May 16, 2007
Last Updated: Monday, May 21, 2007
Bookmark and Share
Protagen will develop protein biochips to analyze quantitative antibody binding profiles and off-target activities of antibody candidates under the collaboration.

Protagen AG has entered into an international collaboration to develop antibodies against liver proteins.

Protagen announced it’s partnership with the Centre for Applied Proteomics (ZAP), Dortmund, Schunde Kangdi Antibody Biotech, Foshan, China and the Beijing Proteome Research Centre (Beijing PRC) at the interna¬tional symposium on High Performance Proteomics in Dortmund.

The involvement of Protagen in the collaboration will be to develop tailor-made protein biochips that can be used to analyze quantitative antibody binding profiles, as well as any off-target activities of antibody candidates.

UNIchip® products of Protagen are versatile research tools that enable antibody development by identifying the most specific antibody candidates at an early stage of development.

ZAP will use UNIchip® to assess around 200 monoclonal antibodies, generated by Schunde Kangdi Antibody Biotech and Beijing PRC. The results will be used to identify those antibodies that are most promising for future develop¬ment as research tools or therapeutics or for use in diagnostic kits. The industrial partners are sharing the worldwide commercialization rights for the antibodies analyzed.

Professor Helmut E. Meyer, Head of the Human Brain Proteome Project and Director of ZAP and Professor Fuchu He, Head of the Human Liver Proteome Project and president of the Beijing PRC, will share the scientific leadership on the project. The two institutes have already worked together for a number of years within the framework of the Human Proteome Organization (HUPO).

Professor Meyer said: “As the proteome is so much more complex than the genome, it is more costly to research. It is therefore useful to work with a number of partners to draw on a wide range of experience and pool resources. We are looking forward to working with Protagen and tapping into the company’s exten¬sive experience in protein research to help us achieve our goals.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

UNIchip Protein Biochips from Protagen Identify Significant Off-target binding for TNF-alpha Inhibitors
Findings could explain side effects seen with these biological drugs for treating rheumatic diseases.
Thursday, April 03, 2008
Protagen Launches GMP Protein Analysis Services
Protagen receives Good Manufacturing Practice certification to provide protein analysis services in accordance with the international quality assurance guidelines.
Wednesday, April 25, 2007
Scientific News
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Genes That Increase Children's Risk Of Blood Infection Identified
A team led by Oxford University has identified genes that make certain children more susceptible to invasive bacterial infections by performing a large genome-wide association study in African children.
Poverty Marks a Gene, Predicting Depression
New study of high-risk teens reveals a biological pathway for depression.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!